In addition, non-small cell lung cancer patients with clinical stages II and III had higher G3BP1 and YB1 protein expression than those with stage I. Furthermore, G3BP1 protein expression was positively correlated with YB1 and pAKT (Zheng et al., 2019). The gene discussed is G3BP1; the disease is non-small cell lung carcinoma.